UPADACITINIB
Clinical trials for UPADACITINIB explained in plain language.
Never miss a new study
Get alerted when new UPADACITINIB trials appear
Sign up with your email to follow new studies for UPADACITINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat Crohn's? drug shows promise in small bowel
Disease control CompletedThis study tested the drug upadacitinib in people with Crohn's disease that only affects the small bowel, a type that is often harder to treat. Researchers compared 3 patients with small-bowel Crohn's to others with Crohn's in different areas, using ultrasound to measure bowel in…
Matched conditions: UPADACITINIB
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New study: does starting this pill sooner save colitis patients from surgery?
Disease control CompletedThis study looked back at medical records of 81 people with severe ulcerative colitis to see if starting upadacitinib early works better than using it after other treatments fail. Researchers checked how many avoided surgery and achieved remission within 12 weeks. The goal is to …
Matched conditions: UPADACITINIB
Sponsor: Xijing Hospital of Digestive Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Head-to-Head: which drug works better for psoriatic arthritis in the real world?
Disease control CompletedThis study looked at 70 people with psoriatic arthritis to compare two drug types: upadacitinib and IL-17 inhibitors. Researchers tracked joint and skin symptoms over 24 weeks in routine care. The goal is to see which works better in real life, helping doctors personalize treatme…
Matched conditions: UPADACITINIB
Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC